Understanding brain function and illness progression in children with severe mood dysregulation
Official title: Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth
Run by National Institutes of Health Clinical Center (CC) · NCT00025935 · Data updated 2026-11-12
This study looks at how severe mood problems affect children and teenagers aged 7-17 by tracking their moods and behaviors to see how their brains change over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years to 85 Years |
| Sex | All |
| Enrollment | 2350 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | January 1, 2002 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT00025935 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children and adolescents aged 7-17 who display symptoms of severe mood dysregulation or disruptive mood dysregulation disorder.
✕Probably not a fit
Patients who do not exhibit significant mood dysregulation or who are outside the age range of 7-17 may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on children and adolescents aged 7-17 who exhibit severe mood dysregulation, characterized by chronic anger, sadness, irritability, and hyperarousal. Researchers aim to describe the moods and behaviors of these individuals while utilizing specialized testing and neuroimaging techniques to investigate the brain changes associated with this condition. The study seeks to differentiate chronic irritability from episodic pediatric bipolar disorder and understand its clinical implications. Participants will be followed longitudinally to assess the progression of symptoms and their impact on daily functioning.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and treatment options for children suffering from severe mood dysregulation.
How similar studies have gone: Other studies have explored similar themes in pediatric mood disorders, but this specific approach focusing on chronic irritability and neuroimaging is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:
1. Inclusion criteria for children with DMDD, subthreshold DMDD:
1.1.1 Ages 7-17 at the time of recruitment; will be followed in the longitudinal component of the study until age 25.
1.1.2 Abnormal mood (specifically, anger, sadness, and/or irritability), present at least half of the day most days (or at least half the day at least one day per week for subthreshold), and of sufficient severity to be noticeable by people in the child's environment (e.g. parents/caregivers, teachers, peers).
1.1.3 Compared to his/her peers, the child exhibits markedly increased reactivity to negative emotional stimuli that is manifest verbally or behaviorally. For example, the child responds to frustration with extended temper tantrums (inappropriate for age and/or precipitating event), verbal rages, and/or aggression toward people or property. Such events occur, on average, at least three times a week. For subthreshold DMDD such tantrums occur on average at least once per month.
1.1.4 The symptoms in # 1.1.2, and 1.1.3 above are currently present and have been present for at least 12 months without any symptom-free periods exceeding three months.
1.1.5 The onset of symptoms must be prior to age 10 years.
1.1.6 For DMDD the symptoms are severe in at least in one setting (e.g. violent outbursts, assaultiveness at home, school, or with peers) and at least mild (distractibility, intrusiveness) in a second setting. For subthreshold DMDD, there must be evidence of impairment causing distress to the child or to those around him/her in at least one setting.
2. Caregivers of children and adolescents with DMDD or subthreshold DMDD enrolled in 02-M-0021
2.1.1. Are capable of performing behavioral tasks and/or scanning.
2.1.2. Speaks English
3. Healthy Volunteer (Control) Children
3.1.1. Control subjects will be group matched to the patients.
3.1.2. Have an identified primary care physician.
3.1.3. Speaks English
4. Healthy Volunteer Adults
4.1.1 Control subjects will be group matched to the patients.
4.1.2. They will have normal physical and neurological examinations by history or checklist
4.1.3. Have an identified primary care physician.
4.1.4 Speaks English
5. Children with Major Depressive Disorder (MDD) Inclusion criteria (all must be met):
5.1.1 Ages 11-17 at the time of recruitment; will be followed in the longitudinal component of the study until age 25.
5.1.2. DSM-IV or DSM-5 Major Depressive Disorder
5.1.2.1 Five or more of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure.
5.1.2.1.1 Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feeling sad, blue, "down in the dumps," or empty) or observation made by others (e.g., appears tearful or about to cry). (In children and adolescents, this may present as an irritable or cranky, rather than sad, mood.)
5.1.2.1.2 Markedly diminished interest or pleasure in all, or almost all, activities every day, such as no interest in hobbies, sports, or other things the person used to enjoy doing.
5.1.2.1.3. Significant weight loss when not dieting or weight gain (e.g., a change of more than 5 percent of body weight in a month), or decrease or increase in appetite nearly every day.
5.1.2.1.4. Insomnia (inability to get to sleep or difficulty staying asleep) or hypersomnia (sleeping too much) nearly every day
5.1.2.1.5. Psychomotor agitation (e.g., restlessness, inability to sit still, pacing, pulling at clothes or clothes) or retardation (e.g., slowed speech, movements, quiet talking) nearly every day
5.1.2.1.6. Fatigue, tiredness, or loss of energy nearly every day (e.g., even the smallest tasks, like dressing or washing, seem difficult to do and take longer than usual).
5.1.2.1.7. Feelings of worthlessness or excessive or inappropriate guilt nearly every day (e.g., ruminating over minor past failings).
5.1.2.1.8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (e.g. appears easily distracted, complains of memory difficulties).
5.1.2.1.9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideas without a specific plan, or a suicide attempt or a specific plan for committing suicide
5.1.2.1.10 Symptoms cause clinically significant distress or impairment in social, occupational/academic, or other important areas of functioning.
5.1.2.1.11. The episode is not attributable to the physiological effects of a substance or to another medical condition.
5.1.3. Youth with MDD who are continuing in research as adults must also be receiving psychiatric care for their MDD, if it is ongoing
6. Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
6.1.1. Age 8-17
6.1.2. Currently meets DSM-IV or DSM-5 criteria for ADHD
6.1.3. Subjects with other primary psychiatric disorders including anxiety disorders, dysthymic disorder, past major depression, oppositional defiant disorder, tic disorders, and the learning, communication, and elimination disorders may be accepted
6.1.4. Have an identified primary care physician.
6.1.5. Speaks English
EXCLUSION CRITERIA:
1.3 Exclusion criteria for those with DMDD:
1.3.1 The individual exhibits any of these cardinal bipolar symptoms:
1.3.1.1 Elevated or expansive mood
1.3.1.2 Grandiosity or inflated self-esteem
1.3.1.3 Decreased need for sleep
1.3.1.4 Increase in goal-directed activity (this can result in the excessive involvement in pleasurable activities that have a high potential for painful consequences)
1.3.1.5. Has BD symptoms in distinct periods lasting more than 1 day.
1.3.2. Meets criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, PDD, or PTSD.
1.3.3. IQ\< 70
1.3.4. The symptoms are due to the direct physiological effects of a drug of abuse, or to a general medical or neurological condition.
1.3.5. Currently pregnant or lactating
1.3.6. Meets criteria for alcohol or substance abuse with the last three months
2\. Exclusion of caregivers of children and adolescents with DMDD or subthreshold DMDD
2.1 Have an I.Q. \< 70
2.2 Have any serious medical condition or condition that interferes with participation
3.2 Healthy Volunteer (Control) Children:
3.2.1. I.Q. \< 70;
3.2.2. Any serious medical condition or condition that interferes with fMRI or MEG/EEG scanning, or fNIRS, pregnant or lactating;
3.2.3. Past or current diagnosis of any anxiety disorder (panic disorder, GAD, Separation Anxiety Disorder, Social Phobia), mood disorder (manic or hypomanic episode, major depression), OCD, PTSD, Conduct Disorder, psychosis, current suicidal ideation, Tourette Disorder, Autism Spectrum Disorder or ADHD.
3.2.4. Substance abuse within two months prior to study participation or present substance abuse
3.2.5. History of sexual abuse.
3.2.6. Parent or sibling with Bipolar Disorder, recurrent MDD, or any disorder with psychosis.
4.2 Healthy Volunteer Adults:
4.2.1. IQ\< 70
4.2.2. Pregnant
4.2.3. Any past or current history of Bipolar Disorder (any manic or hypomanic episode), recurrent MDD, or any disorder with psychosis
5.3 Exclusion criteria for those with MDD:
5.3.1 The individual exhibits any of these cardinal bipolar symptoms:
5.3.1.1 Elevated or expansive mood
5.3.1.2 Grandiosity or inflated self-esteem
5.3.1.3 Decreased need for sleep
5.3.1.4 Increase in goal-directed activity (this can result in the excessive involvement in pleasurable activities that have a high potential for painful consequences)
5.3.1.5. Has BD symptoms in distinct periods lasting more than 1 day.
5.3.2. Meets criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, PDD, or PTSD.
5.3.3. IQ\< 70
5.3.4. The symptoms are due to the direct physiological effects of a drug of abuse, or to a general medical or neurological condition.
5.3.5. Currently pregnant or lactating
5.3.6. Meets criteria for alcohol or substance abuse with the last three months
6.2. Exclusion criteria for those with ADHD:
6.2.1. IQ\<70
6.2.2. Pregnancy
6.2.3. Ongoing medical illness or neurological disorder other than ADHD
6.2.4. Any condition that would interfere with the participants' ability to perform research tasks
6.2.5. Current Major Depression
6.2.6. Any past or present manic or hypomanic episode
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Melissa A Brotman, Ph.D. — National Institute of Mental Health (NIMH)
- Study coordinator: Melissa A Brotman, Ph.D.
- Email: melissa.brotman@nih.gov
- Phone: (301) 435-6645
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ketamine improves pain relief and mood in chronic pain patients
This study is testing whether Ketamine injections can help people with chronic pain and mood disorders feel better both physically and emotionally.
-
Registry for improving mental health care in the Maritimes
This study is trying to improve mental health care for people with depression in the Maritimes by creating a registry that helps track treatments and outcomes while involving those who have experienced these challenges.
-
VLCPUFA-rich fish oil and standard DHA oil: who reaches a higher omega-3 index?
This study tests whether VLCPUFA-rich fish oil raises the blood omega-3 index more than a standard DHA-rich fish oil in healthy adults aged 18–60.
-
Blood biomarkers for immune-related neuropsychiatric conditions
This study tests whether blood biomarkers can help identify neuropsychiatric disorders that may be linked to the immune system in people of any age.
-
First-in-human imaging of PDE4D with [11C]JMJ-129-d2 in healthy volunteers
A new PET tracer called [11C]JMJ-129-d2 is being tested in healthy adults to see if it safely and reliably images the brain’s PDE4D enzyme and to measure how the tracer distributes in the body.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.